uniQure N.V.

-1.87 (-5.27%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.44B
Current PEN/A
Forward PE 124.48
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.27 Million
Adjusted EPS-$0.90
See more estimates
10-Day MA$34.01
50-Day MA$34.77
200-Day MA$39.83
See more pivots

uniQure NV Stock, NASDAQ:QURE

Paasheuvelweg 25a, Amsterdam, Noord-Holland 1105 BP
Phone: +
Number of Employees: 248


uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.